The State Food and Drug Administration (SFDA) of China is investigating the allegation that a consignment of drugs labeled "Made in India" were, in fact, fake pharmaceuticals produced in China.
According to a report in China Daily, SFDA spokesperson Yan Jiangying said: "We are highly concerned about the case and are sending investigating officials to the Chinese provinces involved, including Guangdong."
Yan added the SFDA would continue working with the police in the joint war against fake and inferior drugs in terms of technological support and the handing-over of cases.
Last week the Nigerian Government Drug Regulatory Authority (NAFDAC) reported about the detention of a large consignment of fake anti-malarial generic pharmaceuticals labelled 'Made in India' but produced in China.
"After a laboratory analysis by NAFDAC, the drugs have been found to be fake and had it not been intercepted, about 64,2000 adults would have been affected," it said.
According to the Indian High Commissioner in Nigeria, the consignment containing Maloxine and Amalar tablets, used for the treatment of Malaria, were valued at 32.1 million Naira and were produced, packed and shipped from China.
Quoting SFDA's drug safety inspection bureau director Cui Enxue, the China Daily said overseas pharmacy companies should deal only with registered Chinese drug producers and traders that are recognised by SFDA.